Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Kidney
  • Kidney Transplantation
  • Organ Preservation
  • Perfusion
  • Phentolamine
  • Tissue Donors

abstract

  • Donor treatment with PM immediately before aortic cross-clamp is associated with improved machine perfusion dynamics (renal flow and renal resistance) and lower incidence of DGF compared with donor treatment with H or no treatment. Moreover, MP of renal allografts was associated with improved early function compared with CS grafts.

publication date

  • January 15, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10653402

Additional Document Info

start page

  • 184

end page

  • 6

volume

  • 69

number

  • 1